The explanation that does not hold up
If AI were simply ineffective at drug discovery, its molecules would not be interesting to chemists and would not reach human testing at all. Some have. So the gap is not explained by the tools failing to work.
Filters a candidate must pass after design
- Behaving well in a living body, not just in a model
- Surviving years of testing in human volunteers and patients
- Attracting enough funding to be developed to the end
- Convincing regulators that the evidence supports approval
- Convincing doctors and patients to actually use it
The question is not whether AI can design molecules. It is why designing them well has not yet changed what doctors can prescribe.